Angola vs North Macedonia: Access to anti-retroviral drugs, female
Angola
50.0%
in 2024
North Macedonia
49.0%
in 2024
Angola rank
122nd
North Macedonia rank
123rd
Access to anti-retroviral drugs, female over time
- Angola
- North Macedonia
How they compare
Angola currently reports 50.0% against 49.0% in North Macedonia, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was North Macedonia ahead.
Angola ranks 122nd and North Macedonia ranks 123rd of 141 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 21.2% | 19.5% | North Macedonia |
| 2010s | 20.6% | 45.3% | 24.7% | North Macedonia |
| 2020s | 43.0% | 46.2% | 3.2% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Angola or North Macedonia?
- Angola, at 50.0% against 49.0% in North Macedonia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Angola and North Macedonia?
- 1.0%, with Angola ahead.
- How many years of comparable data are there for Angola and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and North Macedonia rank globally for access to anti-retroviral drugs, female?
- Angola ranks 122nd and North Macedonia ranks 123rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.